Your browser doesn't support javascript.
loading
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans.
Joshi, Kruti; Pilon, Dominic; Shah, Aditi; Holiday, Christopher; Karkare, Swapna; Zhdanava, Maryia.
Affiliation
  • Joshi K; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
  • Pilon D; Analysis Group, Inc., Montréal, QC, Canada.
  • Shah A; Analysis Group, Inc., Montréal, QC, Canada.
  • Holiday C; Analysis Group, Inc., Montréal, QC, Canada.
  • Karkare S; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
  • Zhdanava M; Analysis Group, Inc., Montréal, QC, Canada.
J Med Econ ; 26(1): 422-429, 2023.
Article in En | MEDLINE | ID: mdl-36924214

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Substance-Related Disorders / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant Type of study: Guideline / Health_economic_evaluation / Observational_studies Aspects: Implementation_research Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Substance-Related Disorders / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant Type of study: Guideline / Health_economic_evaluation / Observational_studies Aspects: Implementation_research Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom